首页> 外国专利> COMPOSITIONS AND METHODS FOR DIAGNOSIS OF AUTOPHAGIC VACUOLAR MYOPATHY

COMPOSITIONS AND METHODS FOR DIAGNOSIS OF AUTOPHAGIC VACUOLAR MYOPATHY

机译:诊断自噬性静脉肌病的组合物和方法

摘要

Transmembrane V-ATPase proton pump complexes regulate pH of extracellular space or intracellular compartments of cells. V-ATPase complexes are ubiquitous in cells across species. A human orthologue of yeast vma21, LOC203547 (VMA21), is likely involved in the assembly of the V-ATPase. Hypomorphic mutations of VMA21 are identified from XMEA patients. Methods to diagnose and/or distinguish between different forms of vacuolar or vacuolated myopathy in an individual or patient are provided based either on the sequence of the VMA21 gene and/or the level and/or activity of the V-ATPase complex. Compositions of the present invention may comprise DNA, RNA, or protein molecules corresponding to all or a portion of VMA21 and including one or more of the mutations in VMA21 identified. Cultured cells or cell lines having one or more mutations in the VMA21 gene derived from patients having a form of vacuolar or vacuolated myopathy are provided.
机译:跨膜V-ATPase质子泵复合物调节细胞胞外空间或细胞内区室的pH。 V-ATPase复合物在物种间的细胞中普遍存在。酵母vma21的人类直系同源物LOC203547(VMA21)可能参与了V-ATPase的组装。从XMEA患者中鉴定出VMA21的亚型突变。基于VMA21基因的序列和/或V-ATP酶复合物的水平和/或活性,提供了诊断和/或区分个体或患者的液泡或液化肌病的不同形式的方法。本发明的组合物可以包含对应于全部或部分VMA21并且包括所鉴定的VMA21中的一个或多个突变的DNA,RNA或蛋白质分子。提供了培养细胞或细胞系,所述培养细胞或细胞系在源自具有液泡或液化肌病形式的患者的VMA21基因中具有一个或多个突变。

著录项

  • 公开/公告号US2009311704A1

    专利类型

  • 公开/公告日2009-12-17

    原文格式PDF

  • 申请/专利权人 BERGE A. MINASSIAN;

    申请/专利号US20090477555

  • 发明设计人 BERGE A. MINASSIAN;

    申请日2009-06-03

  • 分类号C12Q1/68;C07H21/04;C12N5/10;

  • 国家 US

  • 入库时间 2022-08-21 18:53:55

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号